(Q46143289)

English

Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle

scientific article published in September 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

author name string

D M Lidgate

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

R C Fu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

N E Byars

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

L C Foster

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

J S Fleitman

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 1989

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

748-752

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The parenteral toxicity of clindamycin 2-phosphate in laboratory animals

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of liposomes prepared using a microemulsifier

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2813271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1015915212195

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/2813271

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46143289&oldid=2112011761"